- Home
- PRPH vs RLMD Comparison
PRPH vs RLMD Comparison
Compare PRPH & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPH
- RLMD
- Stock Information
- Founded
- PRPH 1989
- RLMD 2004
- Country
- PRPH United States
- RLMD United States
- Employees
- PRPH N/A
- RLMD N/A
- Industry
- PRPH Biotechnology: Pharmaceutical Preparations
- RLMD Biotechnology: Pharmaceutical Preparations
- Sector
- PRPH Health Care
- RLMD Health Care
- Exchange
- PRPH Nasdaq
- RLMD Nasdaq
- Market Cap
- PRPH 17.7M
- RLMD 20.3M
- IPO Year
- PRPH 1997
- RLMD N/A
- Fundamental
- Price
- PRPH $0.28
- RLMD $0.56
- Analyst Decision
- PRPH
- RLMD Buy
- Analyst Count
- PRPH 0
- RLMD 3
- Target Price
- PRPH N/A
- RLMD $5.00
- AVG Volume (30 Days)
- PRPH 1.1M
- RLMD 194.2K
- Earning Date
- PRPH 08-13-2025
- RLMD 08-07-2025
- Dividend Yield
- PRPH N/A
- RLMD N/A
- EPS Growth
- PRPH N/A
- RLMD N/A
- EPS
- PRPH N/A
- RLMD N/A
- Revenue
- PRPH $5,845,000.00
- RLMD N/A
- Revenue This Year
- PRPH $221.82
- RLMD N/A
- Revenue Next Year
- PRPH N/A
- RLMD N/A
- P/E Ratio
- PRPH N/A
- RLMD N/A
- Revenue Growth
- PRPH N/A
- RLMD N/A
- 52 Week Low
- PRPH $0.22
- RLMD $0.24
- 52 Week High
- PRPH $3.00
- RLMD $3.98
- Technical
- Relative Strength Index (RSI)
- PRPH 35.31
- RLMD 42.53
- Support Level
- PRPH $0.30
- RLMD $0.57
- Resistance Level
- PRPH $0.35
- RLMD $0.63
- Average True Range (ATR)
- PRPH 0.04
- RLMD 0.05
- MACD
- PRPH -0.01
- RLMD -0.01
- Stochastic Oscillator
- PRPH 1.93
- RLMD 6.89
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.